TrialNature medicine2026
Favipiravir for Lassa fever: an open-label, randomized controlled phase 2 trial.
Cyril Erameh et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it
TrialNature medicine2026
Cyril Erameh et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.